The strategic location of the GLP-certified laboratory close to the clinical research units of the Netherlands Cancer Institute facilitates the support of clinical studies with anticancer drugs with time-critical samples to be analysed (rapid turnaround times for dose escalation studies and therapeutic drug monitoring) and of mass balance studies preventing the shipment of radioactive samples. The co-located clinical research units enables innovative working collaboration with clinicians, efficient analysis and faster progress of clinical studies leading to a reduction in the costs.

Know-how
Our bioanalytical group is comprised of specialists with over 25 years of experience in bioanalysis, cooperation with sponsors and clinics. Our employees are specialised in the development of bioanalytical methods for complex anticancer drugs. We offer validated methods for the quantification of anticancer drugs that are ready for use, including ultra-sensitive methods down to lower limits of quantification of pg/mL in body fluids and methods for the quantification of anticancer drugs in other matrices (PBMCs, tumour tissues and DNA).